Biosimilars and Biologics Market Poised for Remarkable 15.5% CAGR Growth, Eyeing US$95 Billion by 20
The Biosimilars and Biologics Market is expected to grow at a CAGR of 15.5% during the period 2022-2032. The market is valued at US$ 22,490.62 Mn in 2022 and is expected to reach a valuation of US$ 95,021.37 Mn by 2032.FMI, in its business report, elaborates the historical and current scenario of the global Biosimil...
Source: pharmiweb.com